VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024

Recruiting Observational Study
Pneumonia Ventilator Associated
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Centre Hospitalier Sud Francilien · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this observational study is to to analyze respiratory samples performed in mechanically ventilated ICU patients and to assess whether the SRLF criteria for defining VAP were respected among patients admited to the Intensive care medicine at a regional hospital en France

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults ≥ 18 years * Hospitalization in Intensive care unit for the period between 01/01/2022 and 31/12/2024 * Intubation and mechanical ventilation for \> 48h * Positive respiratory sample Exclusion Criteria: * Decision of therapeutic limitation * Organ donors * Patient refu…
Contacts

Luis ENSENYAT MARTIN, MD

33 1 61 69 31 57

luis.ensenyatmartin@chsf.fr

CONTACT

Caroline TOURTE

33 1 61 69 31 50

caroline.tourte@chsf.fr

CONTACT